Health care economist and antitrust expert slams PBMs claims

In a new analysis, a health care economist and antitrust expert called PBMs claims on Medicare price increases “theoretically baseless.

The National Community Pharmacists Association (NCPA) asked Dr. David M. Eisenstadt to analyze a recent PBM cost estimate that said the Ensuring Seniors Access to Local Pharmacies Act (H.R. 4577) would raise Medicare costs by $21 billion over a decade.|

His findings include:

It’s “not a foregone conclusion” that pharmacies that are offering discounted/”preferred” copays would raise their prices if more, competing pharmacies are allowed to provide the same discounts.

The PBMs’ methodology for alleging higher costs is “theoretically baseless” and “neither the actual nor intended formula used to calculate the price increase is supported by any theoretical rationale.”

Read the full NCPA report online here (pdf).